CHO, HYUK JUN,曹赫俊,KIM, JEONG HYEON,金正贤,金正賢,IM, HO TAEK,林昊泽,林昊澤,KIM, YONG IL,金用镒,金用鎰
申请号：
TW108108673
公开号：
TW201944992A
申请日:
2019.03.14
申请国别(地区):
TW
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical combination preparation comprising ezetimibe and rosuvastatin. The pharmaceutical combination preparation has a water activity of 0.40 or less. The pharmaceutical combination preparation can further comprise one or more ingredients selected the group consisting of amlodipine, losartan, and combinations thereof, and the ezetimibe is present in a physically separated state from rosuvastatin, amlodipine, and losartan, respectively.本發明係有關一包含依折麥布(ezetimibe)與瑞舒伐他汀(rosuvastatin)的藥學組合製品。藥學組合製品具有0.40或更低的水活性。藥學組合製品可進一步包含一或多個選自於由安脈狄平(amlodipine)、絡舒坦(losartan)、及其組合所組成群組之成分，且依折麥布分別與瑞舒伐他汀、安脈狄平、及絡舒坦以實體上分開的狀態存在。
